---
figid: PMC5309878__srep42710-f3
figlink: /pmc/articles/PMC5309878/figure/f3/
number: Figure 3
caption: Blue type = enzyme. (a) The 3 dominant pathways leading to the production
  of PC. LysoPCs can be used to make PC or LPA. The effect of decreased lysoPC and
  production of LPA are typed in red. (b) The carnitine shuttle is used to transport
  long chain FAs into the mitochondria to undergo β-oxidation which ultimately leads
  to the final oxidation product (in red), acetyl-CoA. (c) Pathway for the metabolism
  of SMs (and vice versa) to S1P, an important regulator in the liver for fibrosis.
  CK, choline kinase; CT, Cytidine; CDP-choline, cytidine-5′-diphosphocholine; CPT,
  CDP-choline:1,2-diacylglycerol cholinephosphotransferase; PEMT, phosphatidylethanolamine
  N-methyltransferase; PLA2, phospholipase-α2; LCAT, lecithin-cholesterol acyltransferase;
  LPCAT, lysophosphatidylcholine acyltransferase; LPA, lysophosphatidic acid; PC,
  phospatidylcholine; PE, phosphotidylethanolamine; LysoPC, lysophosphatidylcholine;
  TNF-α, tumor necrosis factor-α; IL-1β, interleukin-1β; SCD1, stearoyl-CoA desaturase
  1; CPT1,2, carnitine palmitoyltransferase 1,2; CACT, carnitine-acylcarnitine translocase;
  LCAcylCoA dehydrogenase, long chain acyl-CoA dehydrogenase; NSMase, neutral sphingomyelinase;
  ASMase, acidic sphingomyelinase; SM synthase, sphingomyelin synthase; S1P, sphingosine-1-phosphate.
pmcid: PMC5309878
papertitle: Serum lipid alterations identified in chronic hepatitis B, hepatitis B
  virus-associated cirrhosis and carcinoma patients.
reftext: Tao Wu, et al. Sci Rep. 2017;7:42710.
pmc_ranked_result_index: '158670'
pathway_score: 0.946378
filename: srep42710-f3.jpg
figtitle: Serum lipid alterations identified in chronic hepatitis B, hepatitis B virus-associated
  cirrhosis and carcinoma patients
year: '2017'
organisms: Homo sapiens
ndex: f59d21f2-def9-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5309878__srep42710-f3.html
  '@type': Dataset
  description: Blue type = enzyme. (a) The 3 dominant pathways leading to the production
    of PC. LysoPCs can be used to make PC or LPA. The effect of decreased lysoPC and
    production of LPA are typed in red. (b) The carnitine shuttle is used to transport
    long chain FAs into the mitochondria to undergo β-oxidation which ultimately leads
    to the final oxidation product (in red), acetyl-CoA. (c) Pathway for the metabolism
    of SMs (and vice versa) to S1P, an important regulator in the liver for fibrosis.
    CK, choline kinase; CT, Cytidine; CDP-choline, cytidine-5′-diphosphocholine; CPT,
    CDP-choline:1,2-diacylglycerol cholinephosphotransferase; PEMT, phosphatidylethanolamine
    N-methyltransferase; PLA2, phospholipase-α2; LCAT, lecithin-cholesterol acyltransferase;
    LPCAT, lysophosphatidylcholine acyltransferase; LPA, lysophosphatidic acid; PC,
    phospatidylcholine; PE, phosphotidylethanolamine; LysoPC, lysophosphatidylcholine;
    TNF-α, tumor necrosis factor-α; IL-1β, interleukin-1β; SCD1, stearoyl-CoA desaturase
    1; CPT1,2, carnitine palmitoyltransferase 1,2; CACT, carnitine-acylcarnitine translocase;
    LCAcylCoA dehydrogenase, long chain acyl-CoA dehydrogenase; NSMase, neutral sphingomyelinase;
    ASMase, acidic sphingomyelinase; SM synthase, sphingomyelin synthase; S1P, sphingosine-1-phosphate.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - LPCAT2
  - LPA
  - LPCAT3
  - PLA2G7
  - LPCAT1
  - SMPD2
  - PC
  - LCAT
  - PLA2G2A
  - LPCAT4
  - ADCY8
  - ADCY10
  - ADCY5
  - PLA2G4A
  - PLA2G2F
  - IL1B
  - PLA2G3
  - PEMT
  - PLA2G5
  - ADCY4
  - PLA2G2D
  - PLA2G1B
  - ADCY9
  - PLA2G12A
  - HTATIP2
  - CPT2
  - PLA2G10
  - TNF
  - ADCY1
  - PLA2G6
  - ADCY2
  - PLA2G4D
  - PLA2G2E
  - PLA2G2C
  - CHPT1
  - ADCY3
  - PLA2G12B
  - PLA2G4C
  - SLC25A20
  - ADCY7
  - ADCY6
genes:
- word: LPCAT1-4
  symbol: LPCAT2
  source: hgnc_symbol
  hgnc_symbol: LPCAT2
  entrez: '54947'
- word: LPA
  symbol: LPA
  source: hgnc_symbol
  hgnc_symbol: LPA
  entrez: '4018'
- word: LPCAT1-4
  symbol: LPCAT3
  source: hgnc_symbol
  hgnc_symbol: LPCAT3
  entrez: '10162'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G7
  entrez: '7941'
- word: LPCAT1-4
  symbol: LPCAT1
  source: hgnc_symbol
  hgnc_symbol: LPCAT1
  entrez: '79888'
- word: NSMase
  symbol: nSMase
  source: hgnc_alias_symbol
  hgnc_symbol: SMPD2
  entrez: '6610'
- word: PC
  symbol: PC
  source: hgnc_symbol
  hgnc_symbol: PC
  entrez: '5091'
- word: LCAT
  symbol: LCAT
  source: hgnc_symbol
  hgnc_symbol: LCAT
  entrez: '3931'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2A
  entrez: '5320'
- word: LPCAT1-4
  symbol: LPCAT4
  source: hgnc_symbol
  hgnc_symbol: LPCAT4
  entrez: '254531'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY8
  entrez: '114'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY10
  entrez: '55811'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY5
  entrez: '111'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G4A
  entrez: '5321'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2F
  entrez: '64600'
- word: IncreaseTNFA,IL-1B
  symbol: IL-1B
  source: hgnc_alias_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G3
  entrez: '50487'
- word: PEMT
  symbol: PEMT
  source: hgnc_symbol
  hgnc_symbol: PEMT
  entrez: '10400'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G5
  entrez: '5322'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY4
  entrez: '196883'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2D
  entrez: '26279'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G1B
  entrez: '5319'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY9
  entrez: '115'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G12A
  entrez: '81579'
- word: АCАCС3-ОН
  symbol: CC3
  source: hgnc_alias_symbol
  hgnc_symbol: HTATIP2
  entrez: '10553'
- word: CPT2
  symbol: CPT2
  source: hgnc_symbol
  hgnc_symbol: CPT2
  entrez: '1376'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G10
  entrez: '8399'
- word: TNFA,
  symbol: TNF-alpha
  source: hgnc_alias_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY1
  entrez: '107'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G6
  entrez: '8398'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY2
  entrez: '108'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G4D
  entrez: '283748'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2E
  entrez: '30814'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G2C
  entrez: '391013'
- word: CPT1
  symbol: CPT1
  source: hgnc_alias_symbol
  hgnc_symbol: CHPT1
  entrez: '56994'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY3
  entrez: '109'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G12B
  entrez: '84647'
- word: PLA2
  symbol: PLA2
  source: bioentities_symbol
  hgnc_symbol: PLA2G4C
  entrez: '8605'
- word: CACT
  symbol: CACT
  source: hgnc_prev_symbol
  hgnc_symbol: SLC25A20
  entrez: '788'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY7
  entrez: '113'
- word: AC
  symbol: AC
  source: bioentities_symbol
  hgnc_symbol: ADCY6
  entrez: '112'
chemicals: []
diseases: []
---
